This Month's Tiny Gems - February 2014
Amarin Corp. (AMRN)
Amarin is engaged in commercializing and developing therapeutics to improve cardiovascular health. Vascepa(R) is Amarin's first FDA-approved product as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Amarin refers to this as the MARINE indication.
Discovery Laboratories, Inc. (DSCO)
Discovery Laboratories is a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care. The company’s technology platforms include a novel proprietary KL4 surfactant and proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies.
Kreisler Manufacturing Corp. (KRSL)
Kreisler Manufacturing, through its wholly owned subsidiary Kreisler Industrial Corporation, manufactures precision metal components and manifold and tube assemblies for use in military and commercial aircraft engines and industrial gas turbines.
Stemline Therapeutics, Inc. (STML)
Stemline Therapeutics is engaged in the development of oncology products that target both tumor bulk and cancer stem cells (CSCs). Whereas most cancer therapies target only the tumorm mass, leaving CSCs unaffected and leading to a recurrence of the tumor, Stemline's therapies are specifically designed to attack the tumor and CSCs to induce response and prolong survival.